Cargando…
Poor Humoral Response to Sars-Cov-2 Vaccination Early after Hematopoietic Cell Transplantation: Interim Results of Prospective Study (NCT04723706)
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930043/ http://dx.doi.org/10.1016/S2666-6367(22)00295-0 |
_version_ | 1784670976635568128 |
---|---|
author | Mazur, Izabela Elgamal, Mohamed Mikulandric, Nancy Neme, Klodiana German, Angela Michael Emole, Josephine Abidi, Muneer H. Peres, Edward Ramesh, Mayur Farhan, Shatha |
author_facet | Mazur, Izabela Elgamal, Mohamed Mikulandric, Nancy Neme, Klodiana German, Angela Michael Emole, Josephine Abidi, Muneer H. Peres, Edward Ramesh, Mayur Farhan, Shatha |
author_sort | Mazur, Izabela |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8930043 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89300432022-03-18 Poor Humoral Response to Sars-Cov-2 Vaccination Early after Hematopoietic Cell Transplantation: Interim Results of Prospective Study (NCT04723706) Mazur, Izabela Elgamal, Mohamed Mikulandric, Nancy Neme, Klodiana German, Angela Michael Emole, Josephine Abidi, Muneer H. Peres, Edward Ramesh, Mayur Farhan, Shatha Transplant Cell Ther (Pharm) Pharmacy Nia Grant Update and Best Abstracts American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2022-03 2022-03-18 /pmc/articles/PMC8930043/ http://dx.doi.org/10.1016/S2666-6367(22)00295-0 Text en Copyright © 2022 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | (Pharm) Pharmacy Nia Grant Update and Best Abstracts Mazur, Izabela Elgamal, Mohamed Mikulandric, Nancy Neme, Klodiana German, Angela Michael Emole, Josephine Abidi, Muneer H. Peres, Edward Ramesh, Mayur Farhan, Shatha Poor Humoral Response to Sars-Cov-2 Vaccination Early after Hematopoietic Cell Transplantation: Interim Results of Prospective Study (NCT04723706) |
title | Poor Humoral Response to Sars-Cov-2 Vaccination Early after Hematopoietic Cell Transplantation: Interim Results of Prospective Study (NCT04723706) |
title_full | Poor Humoral Response to Sars-Cov-2 Vaccination Early after Hematopoietic Cell Transplantation: Interim Results of Prospective Study (NCT04723706) |
title_fullStr | Poor Humoral Response to Sars-Cov-2 Vaccination Early after Hematopoietic Cell Transplantation: Interim Results of Prospective Study (NCT04723706) |
title_full_unstemmed | Poor Humoral Response to Sars-Cov-2 Vaccination Early after Hematopoietic Cell Transplantation: Interim Results of Prospective Study (NCT04723706) |
title_short | Poor Humoral Response to Sars-Cov-2 Vaccination Early after Hematopoietic Cell Transplantation: Interim Results of Prospective Study (NCT04723706) |
title_sort | poor humoral response to sars-cov-2 vaccination early after hematopoietic cell transplantation: interim results of prospective study (nct04723706) |
topic | (Pharm) Pharmacy Nia Grant Update and Best Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930043/ http://dx.doi.org/10.1016/S2666-6367(22)00295-0 |
work_keys_str_mv | AT mazurizabela poorhumoralresponsetosarscov2vaccinationearlyafterhematopoieticcelltransplantationinterimresultsofprospectivestudynct04723706 AT elgamalmohamed poorhumoralresponsetosarscov2vaccinationearlyafterhematopoieticcelltransplantationinterimresultsofprospectivestudynct04723706 AT mikulandricnancy poorhumoralresponsetosarscov2vaccinationearlyafterhematopoieticcelltransplantationinterimresultsofprospectivestudynct04723706 AT nemeklodiana poorhumoralresponsetosarscov2vaccinationearlyafterhematopoieticcelltransplantationinterimresultsofprospectivestudynct04723706 AT germanangelamichael poorhumoralresponsetosarscov2vaccinationearlyafterhematopoieticcelltransplantationinterimresultsofprospectivestudynct04723706 AT emolejosephine poorhumoralresponsetosarscov2vaccinationearlyafterhematopoieticcelltransplantationinterimresultsofprospectivestudynct04723706 AT abidimuneerh poorhumoralresponsetosarscov2vaccinationearlyafterhematopoieticcelltransplantationinterimresultsofprospectivestudynct04723706 AT peresedward poorhumoralresponsetosarscov2vaccinationearlyafterhematopoieticcelltransplantationinterimresultsofprospectivestudynct04723706 AT rameshmayur poorhumoralresponsetosarscov2vaccinationearlyafterhematopoieticcelltransplantationinterimresultsofprospectivestudynct04723706 AT farhanshatha poorhumoralresponsetosarscov2vaccinationearlyafterhematopoieticcelltransplantationinterimresultsofprospectivestudynct04723706 |